https://www.marketscreener.com/quote/stock/CHUGAI-PHARMACEUTICAL-CO--6491165/news/Chugai-Pharmaceutical-Mosunetuzumab-Achieved-Primary-Endpoint-in-Expansion-Cohort-of-Japanese-Phas-45922297/?utm_source=telegram&utm_medium=social&utm_campaign=share